EU-funded projects

PB010 PureSelect2

Service technology platform for discovery of antibody fragments with therapeutic and diagnostic potential

Innovative modular PureApta service platform for selection of modified aptamers with diagnostic and therapeutic potential

Development of alternative CAR constructs targeted against refractory B-cell malignancies

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.